About China Cord Blood
China Cord Blood is a company based in Hong Kong (China) founded in 2003.. China Cord Blood has completed 1 acquisition, including Cellenkos. China Cord Blood offers products and services including Bocoran Terpercaya and Rekapan Result Toto. China Cord Blood operates in a competitive market with competitors including StemCyte, Generate, LaCell, Forever Labs and Provia Labs, among others.
- Headquarter Hong Kong, China
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of China Cord Blood
China Cord Blood offers a comprehensive portfolio of products and services, including Bocoran Terpercaya and Rekapan Result Toto. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers accurate Toto number predictions based on statistical patterns.
Provides real-time recaps of Toto results for quick user access.
Funding Insights of China Cord Blood
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $65.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2012 | Amount | Post-IPO - China Cord Blood | Valuation |
investors |
|
| Jun, 2007 | Amount | Private Equity Round - China Cord Blood | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in China Cord Blood
China Cord Blood has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include KKR and EW Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by China Cord Blood
China Cord Blood has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cellenkos. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
T-cell therapeutics are developed for autoimmune and inflammatory diseases.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - China Cord Blood
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
China Cord Blood Comparisons
Competitors of China Cord Blood
China Cord Blood operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemCyte, Generate, LaCell, Forever Labs and Provia Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Umbilical cord blood stem cell transplantation and therapeutic products company
|
|
| domain | founded_year | HQ Location |
Provider of services for the storage of stem cells
|
|
| domain | founded_year | HQ Location |
Stem Cell Production
|
|
| domain | founded_year | HQ Location |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| domain | founded_year | HQ Location |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on China Cord Blood
Frequently Asked Questions about China Cord Blood
When was China Cord Blood founded?
China Cord Blood was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Where is China Cord Blood located?
China Cord Blood is headquartered in Hong Kong, China.
Who is the current CEO of China Cord Blood?
Arashiyama Rui is the current CEO of China Cord Blood.
What does China Cord Blood do?
Founded in 2003 and based in Hong Kong, China, the company operates in the biobanking sector focused on umbilical cord blood stem cells. Storage services are offered to parents for preserving cord blood stem cells from newborns. Operations center on collection, processing, and long-term cryopreservation of these cells for potential medical use. The domain globalcordbloodcorp.com is utilized for its online presence. Leadership includes co-CEOs Arashiyama Rui and Zheng Ting.
Who are the top competitors of China Cord Blood?
China Cord Blood's top competitors include StemCyte, Forever Labs and LaCell.
What products or services does China Cord Blood offer?
China Cord Blood offers Bocoran Terpercaya and Rekapan Result Toto.
How many acquisitions has China Cord Blood made?
China Cord Blood has made 1 acquisition, including Cellenkos.
Who are China Cord Blood's investors?
China Cord Blood has 2 investors. Key investors include KKR, and EW Healthcare Partners.